Scoop: Rakuten Med­ical tar­gets year-end close for $100M+ Se­ries E to fund pho­toim­munother­a­py pipeline: #Jef­feries23

Rakuten Med­ical is aim­ing to close its Se­ries E raise be­fore the end of the year, with the funds de­signed to add fu­el to its pho­toim­munother­a­py clin­i­cal tri­als. As of this week, the com­pa­ny has dock­et­ed $107-108 mil­lion, End­points News has learned.

“The mar­ket sit­u­a­tion is re­al­ly tough but we are in good shape,” co-CEO and pres­i­dent Takashi Toraishi told End­points on the side­lines of the Jef­feries health­care meet­ing Wednes­day. Since the fundraise is still on­go­ing, Toraishi de­clined to dis­close the ex­act tar­get size of the raise.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER